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Objective: The aim of this study was to investigate the benefits of deferred routine computed 
tomography of the kidneys, ureters and bladder (CT KUB) for patients with a self-limiting 
episode of suspected urolithiasis. Material and methods: The study comprised a case series 
of consecutive patients examined with deferred routine CT KUB for control of suspected 
urolithiasis. Patients examined with CT KUB at the University Hospital of North Norway, 
between 1 January 2010 and 31 December 2013, were included. The final analysis included 
189 CT KUBs (response rate 48%). All data were extracted from the patient case files. The 
primary endpoint was the proportion of asymptomatic patients with a confirmed diagnosis of 
urolithiasis on CT KUB that led to surgical intervention within 1 year from the initial CT 
scan. Results: At the time of CT KUB 171 (90%) patients were asymptomatic, of whom three 
(1.8%) were treated. Urolithiasis was confirmed on CT KUB in 23% of asymptomatic 
patients. Conclusion: Deferred CT KUB did not alter clinical outcome for the great majority 
of asymptomatic patients. The majority of patients that received adequate pain relief in 
primary care remained asymptomatic, and did not need specialized healthcare. To refrain 
from CT KUB involves little risk. Deferred CT KUB for patients with suspected urolithiasis is 
a low-value healthcare service.  
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Introduction: 
Calculi in the urinary tract are common: in the USA one person in 11 will have a kidney stone 
during their lifetime [1]. It is unknown whether the observed increase in urolithiasis [1-3] is 
due to a real increase in incidence, an increased use and sensitivity of imaging modalities [4] 
and/or lower threshold for contacting the healthcare system. The charges for emergency 
department visits for urolithiasis increased by 10% annually between 2006 and 2009, and 
amounted to 5 billion USD in 2009 [2]. Emergency department visits due to flank or kidney 
pain increased significantly from 1996 to 2007, together with a more than tenfold increase in 
the use of CT KUB. The proportion that was diagnosed with urolithiasis was not increased 
[5]. 
There is consensus in the urology community that patients presenting with suspected 
urolithiasis should have their tentative diagnosis supported by appropriate imaging. The 
European Association of Urology (EAU), The American Urological Association (AUA), and 
American College of Radiology recommend CT KUB because of the high sensitivity and 
specificity compared to other imaging modalities [6-8]. The high expenses and radiation 
exposure associated with CT KUB cause for concern [2, 5, 6, 8]. In the EUAs 2015 guideline 
ultrasound is now described as the preferred initial imaging modality. Still the 
recommendation on CT KUB remains: “Following initial ultrasound assessment, non contrast 
computerized tomography should be used to confirm a stone diagnosis in patients presenting 
with acute flank pain, because it is superior to intravenous urography” [6]. 
The guidelines do not specify when to suspect urolithiasis, when to refer a patient for 
CT KUB and when not to. The EUA states: ”Patients with ureteral stones usually present with 
loin pain, vomiting, and sometimes fever, but may also be asymptomatic” [6]. When to 
suspect urolithiasis is therefore largely left to the individual physician´s clinical discretion. 
The guidelines do not describe management of suspected urolithiasis in primary care.  
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Most ureteral stones pass spontaneously [7, 9, 10]. Only 1.1% of asymptomatic stones 
need intervention [11]. In Norway, patients with ongoing severe symptoms of suspected 
urolithiasis are commonly hospitalized acutely. However, in cases where the pain resolves 
either spontaneously or conservatively they are discharged from the emergency room or leave 
their general practitioner (GP) with a referral to CT KUB within 2-6 weeks [12]. The practice 
is not based on evidence of patient outcomes. The argument is that most ureteral stones pass 
spontaneously within 40 days [3, 9], and a deferred CT KUB can both control passage and be 
diagnostic for stones remaining after the expected time of passage.  
Objective: 
We aimed to investigate the clinical benefits for patients managed with deferred routine CT 
KUB after a self-limiting initial episode of suspected urolithiasis. 
 
Materials and methods: 
Study design: 
This study is a case-series of consecutive patients investigated with deferred CT KUB. We 
determined the probability of a positive finding of urolithiasis and the extent of interventions 
performed on both symptomatic and asymptomatic patients.  
 
Setting:  
The University Hospital of Northern Norway (UNN) is a state owned hospital with locations 
in Tromsø, Harstad and Narvik. UNN is the local hospital for 200,000 inhabitants. In the 
attachment area there are no other CT scan providers. The GP refers the patients to 




From a search of patient case files at UNN from 1 January 2010 to 31 December 2013, 
patients with suspected urolithiasis and deferred CT KUB were identified and included on the 
basis of the referral information. All patients referred to CT KUB with a suspicion of 
urolithiasis were included, regardless of how the symptoms were described. Patients with a 
CT-verified calculus within 1 year before the CT where the calculus was not removed, 
patients under 18 years of age, pregnant patients and patients with persistent symptoms for 
more than 3 weeks at the time of referral were excluded from the study.   
The inclusion criteria were fulfilled in 438 patients of whom 28 were not invited, 10 
because they had died and 18 because we could not get a contact address. Patients were 
contacted by letter with information of the study and a consent form. Among 410 invited 
patients, 197 (48%) accepted to participate and gave us permission to study their hospital 
records (fig. I). Fourteen cases were excluded from the analysis because further investigation 
of their hospital record showed that five patients had symptoms for more than three weeks at 
the time of referral, four patients had a stone diagnosis within 1 year prior to the CT and five 
patients had been converted to immediate imaging due to worsening of clinical symptoms. Six 
participants had two independent episodes of suspected urolithiasis and were referred to 
deferred CT KUB twice in the period of investigation yielding 203 CT KUBs. Final analysis 
included 189 CT KUBs.  
 
Data collection: 
All data was extracted from the patient case files. CT findings, age, gender, previously known 
urolithiasis, time from symptom onset to referral, time from referral to CT imaging, clinical 
symptoms after referral, additional imaging diagnostics, urologic appointments, and treatment 




The Regional Committee for Medical and Health Research Ethics approved the study. Written 
consent was obtained from all participants.  
 
Outcome Measurements and Statistical Analysis: 
The primary endpoint was the proportion of asymptomatic patients with a confirmed 
diagnosis of urolithiasis on CT KUB that led to surgical intervention within one year from the 
initial CT scan. Patients with absence of pain or discomfort by the time of CT KUB were 
classified as asymptomatic. For patients without any clinical follow-up visit at the hospital, 
the authors had no knowledge about symptoms after the CT referral. These patients were 
classified as asymptomatic in the analysis, as they did not exhibit symptoms judged necessary 
of specialized healthcare. Surgical intervention was defined as any intervention performed to 
treat or alleviate urolithiasis, including extracorporeal shock wave lithotripsy, ureteroscopic 
lithotripsy, and ureteral stenting among others. At UNN, common indications for active stone 
removal are severe or persistent symptoms of urolithiasis combined with a confirmed 
radiological diagnosis. Interventions in asymptomatic patients were regarded as interventions 
induced by the CT KUB.  
The secondary endpoints were the proportion of asymptomatic patients and the 
amount of intervention performed on symptomatic patients. Logistic regression analysis of the 
probability of both positive findings and intervention were performed with the following 
covariates: age, gender, haematuria, previously known urolithiasis, duration of symptoms at 




Out of 189 CT KUBs, 79 (42%) were performed on women and 110 (58%) on men (table I). 
The mean age was 55 years. The majority was referred to CT KUB after maximum one day of 
symptoms.  GPs had ordered 95% of the referrals. By the time of CT KUB 90% were 
asymptomatic of whom 23% got a confirmed diagnosis of urolithiasis (table II). Three 
asymptomatic patients underwent surgical intervention.  
 Of asymptomatic patients with a confirmed diagnosis of urolithiasis 25 had kidney 
stones, 11 ureteral stones, and 4 bladder stones (table III). The majority had one stone while 
10 patients had two to nine stones, all located in the kidneys. Median size for all calculi was 4 
mm (range 1-17). Median size for kidney and ureteral stones were 3 mm (1-14) and 4 mm (3-
7), respectively. Hydronephrosis was present in two asymptomatic patients, of whom one 
received intervention and one passed a 3 mm ureteral stone spontaneously. The subsequent 
follow-up CT showed no sign of hydronefrosis. In 168 patients, there was no information on 
urolithiasis in the case record after referral, including 37 patients with positive CT. Of these 
patients, 24 had kidney stones, nine ureteral stones, and four bladder stones, median stone size 
was 3.5 mm.  
 In logistic regression analysis, only gender was significant in the probability of 
positive findings, with an odds ration of 2.50 for men (p = 0.025, 95% confidence interval 
1.12 – 5.58). None of the variables were significant predictors for intervention.  
 The characteristics of asymptomatic patients who received intervention are shown in 
table IV. Three male patients were classified as asymptomatic, and got treatment, two with 
ureteral stones and one with a kidney stone. Out of 18 symptomatic patients, 12 underwent 
surgical intervention and six passed a stone spontaneously. The characteristics of 
symptomatic patients that received intervention are shown in table V. All symptomatic 
patients that were treated had symptoms for a minimum of seven weeks before intervention. 
Four symptomatic patients had hydronephrosis, all were treated.   
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 Follow-up for conditions other than urolithiasis revealed on CT KUB was offered to 
20 patients (11%). Four patients received treatment, one each for small intestine 
adenocarcinoma, bladder cancer, ureterocele, and gallstones. The carcinoid tumour was an 
incidental finding, while the three other patients presented symptoms that induced 
intervention. CT findings of possible calculi or incidental findings of possible malignant 
processes resulted in both imaging and physician consultation for 16 patients. All 16 cases 
were concluded with benign conditions with no need of treatment.  
 
Discussion: 
This study found close to no benefit of CT KUB for patients remaining asymptomatic after a 
self-limiting episode of suspected urolithiasis. The great majority of patients with suspected 
urolithiasis that do not need immediate specialized care, do not need specialized care at all. In 
this population 90 % of patients remained asymptomatic and without specialized healthcare 
follow-up. 
These data suggest that routine CT KUB for all patients with suspected urolithiasis 
represents a low-value healthcare service. The risk associated with refraining from CT KUB 
for asymptomatic patients is marginal. Only one examined patient had an asymptomatic 
calculus that caused persistent hydronephrosis, which untreated could represent a risk for 
kidney damage. There is international attention to reduce the use of medical interventions that 
provide no or marginal benefit [13, 14]. Overuse of CT is of public concern [15] and we argue 
that managing self-limiting episodes of urolithiasis with routine CT KUB is overdiagnosis, 
and accordingly should be avoided. 
Surgical treatment was offered to three patients with registered symptoms for less than 
1 month. For the 62-year-old patient with ureteral calculi and hydronephrosis, active stone 
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removal was induced by the CT KUB. For the other ureteral patient, the case record is 
insufficient in regard of symptoms. The available sources gave no information on his 
symptoms and one can only speculate on whether symptoms or the CT image itself caused the 
intervention. The final treated asymptomatic patient had a kidney stone without 
hydronephrosis, which had been asymptomatic for six months. It is questionable if this 
intervention was necessary as there is no advantage of prophylactic treatment of 
asymptomatic calyceal stones [6].  
The present findings also indicate that the practice of deferred imaging is safe, as 
Lindqvist et al. have demonstrated [16]. The majority that got a confirmed diagnosis of 
urolithiasis had calculi smaller than 5 mm in renal calices, calculi that most often are 
asymptomatic [6]. Two asymptomatic patients got a confirmed diagnosis of kidney stones that 
were 6 mm or smaller on their CT KUB while their ureter was slightly dilated. The calculi 
causing the symptoms of urolithiasis had most probably already passed at the time of CT 
KUB. Knowing this, it is reasonable to believe that the symptoms of a proportion of patients 
had no connection to the finding on CT KUB, and thus the benefit of the confirmed diagnosis 
questionable. It is impossible to assess if whether the total 69% with negative CT KUBs had 
passed a calculus already or were suffering symptoms of other conditions than urolithiasis.  
Hydronephrosis was present in 22% of symptomatic patients. The symptomatic 
patients in our analyses constitute a subgroup easily identified by the persistence of their 
symptoms, everyone had symptoms for more than 7 weeks before intervention. Our results 
show that patients with persistent symptoms should have imaging examination both for 
treatment planning and for the assessment of possible hydronephrosis.  
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GPs had ordered almost every CT, which demonstrates that the decision of deferred 
CT is made in primary care. This corresponds well with the clinical distinction between 
patients with urgent need of hospitalization for severe symptoms of urolithiasis and patients 
with a shorter self-limiting episode. The results indicate that almost every patient admitted to 
our hospital acutely get their CT KUB during the admission.  
 The extensive cost and considerable radiation exposure of CT KUB for managing 
urolithiasis are well documented [2, 8, 17]. In a multicentre study Smith-Bindman et al. 
compared patient outcomes when initial investigation was ultrasound or CT KUB 
respectively, and found no significant differences in complication rates, pain scores, 
emergency department visits or hospitalization rates. The CT KUB group had a significantly 
higher radiation exposure [17]. Many recommend ultrasound as the primary imaging modality 
[6, 17-19]. Ultrasound screening for asymptomatic patients would in our population have 
detected potential damaging conditions due to urolithiasis with equal sensitivity as CT KUB. 
The sensitivity of ultrasound detecting hydronephrosis is close to 100 % [20]. Therefore, we 
support the recommendation of ultrasound as the primary modality if imaging diagnostics are 
chosen for asymptomatic patients.  
However, implementation of low-dose CT KUB can limit the radiation exposure down 
to 0.6 mSv[21], and would make the radiation argument of avoiding CT less relevant. Falling 
outside of the scope of our study, further research should assess the costs of deferred 
ultrasound diagnostics compared to low-dose CT KUB. Also the cost and clinical implication 
of incidental findings of the two modalities should be assessed.   
 As reported by others, the positive rate for urolithiasis was lower for women than men, 
[18, 19] and could not be explained by other covariates. No asymptomatic woman was treated 
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for urolithiasis. Special caution towards the use of CT KUB in women has been advocated 
[18, 19]. Our results support this recommendation. 
Apart for one incidental finding of a gastrointestinal tumour, patients treated for other 
conditions than urolithiasis had persistent symptoms. These patients would probably have 
been recognised and treated without routine CT KUB after a self-limiting episode of 
suspected urolithiasis. In this group, there were more patients receiving unnecessary follow-
ups for findings that turned out to be benign, than patients being treated for urolithiasis. The 
economical burden of incidental findings is substantial while the medical benefit is 
questionable [22]. The one incidental finding of clinical importance is not an argument for 
routine CT KUB.  
The strength of our study is the fact that UNN is the only provider of specialized care 
and CT diagnostics in the area, creating a representative patient population. The participation 
rate was only 48%, however such a rate is not uncommon when postal written consent has to 
be obtained several years after the relevant episode. The degree to which this sample is 
representative for all patients examined with CT KUB is therefore hard to assess. It is 
nevertheless reasonable to believe that patients more afflicted with urolithiasis are more 
motivated than others to participate in a urolithiasis study. It is therefore not likely that the 
low benefit conclusion is threatened by a low participation rate.  
The information in some of the referral letters was insufficient. For some of the 
patients, the duration of symptoms at referral, status for haematuria and previously known 
urolithiasis, and/or symptoms after referral were not known. Furthermore, the descriptions of 
pain were sometimes imprecise. Our study cannot answer how primary care physicians dealt 
with the CT findings. Further studies are warranted to assess if more information on duration 
and characteristics of symptoms better can identify potential subgroups with increased or 
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diminished risk associated with refraining from imaging diagnostics. Separate gender and age 
analysis should be performed.  
In conclusion, the practise of imaging diagnostics for all patients with suspected 
urolithiasis is not evidence based. In this study the great majority of patients with suspected 
urolithiasis that received adequate pain relief in primary care remained asymptomatic, and did 
not need specialized healthcare. Deferred CT KUB did not alter clinical outcome for the great 
majority of asymptomatic patients. Refraining from CT KUB involves little risk. Deferred CT 
KUB for patients with suspected urolithiasis is a low-value healthcare service. The authors 
recommend that its routine use should be avoided and replaced by a process of shared 
decision making. Asymptomatic patients should receive information on benefits and risks of 
imaging examination, in addition to thorough information on when to seek help again. If 
experiencing persistent symptoms, CT KUB should be recommended.  
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